QA: Minerva Neurosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001598646_2023_Minerva_Neurosciences_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Promis Neurosciences Inc', 'shared_tokens': {'neurosciences'}}]}

Graph

Absolute values for 0001598646, Minerva Neurosciences Inc

  xvar xval
0 AssetsCurrent 40,158,941
1 IntangibleAssetsNetIncludingGoodwill 14,869,399
2 PropertyPlantAndEquipmentNet 16,326
3 remainder_Assets 42,567
4 LiabilitiesCurrent 1,377,576
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 73,733,876
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,933,400
9 ResearchAndDevelopmentExpense 20,475,515
10 remainder_Expenses 6,510,845
11 remainder_Revenues 0
12 remainder_NetIncome 734,944
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 55,087,233
1 Liabilities 75,111,452
2 Expenses 35,919,760
3 Revenues 0
4 StockholdersEquity -20,024,219
5 NetIncome -35,184,816
6 ComprehensiveNetIncome -35,184,816
7 BaseVar 83,426,694
8 EconomicCapitalRatiobeforeLimitedLiability -1.21
9 EconomicCapitalRatio 1.25

Edgar->Model Mapping

Feature Distribution

Change over Time